Thermo Fisher Scientific Inc reports results for the quarter ended December 31 - Earnings Summary

• Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $6.10​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $5.67. The mean expectation of twenty five analysts for the quarter was for earnings of $5.94 per share. Wall Street expected results to range from $5.71 to $6.00 per share.
• Revenue rose 4.7% to $11.40 billion from a year ago; analysts expected $11.28 billion.
• Thermo Fisher Scientific Inc's reported EPS for the quarter was $4.78​.
• The company reported quarterly net income of $1.83 billion.
• Thermo Fisher Scientific Inc shares had risen by 9.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.1% in the last three months.​
• In the last 30 days, four analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 27 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."
• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Thermo Fisher Scientific Inc is $646.00

This summary was machine generated from LSEG data January 30 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)